Status:
COMPLETED
Incidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Diabetes Mellitus, Type 2
Catheterization, Peripheral
Eligibility:
All Genders
40-90 years
Brief Summary
Diabetes Mellitus type 2 (T2DM) is one of the most frequent metabolic diseases worldwide. It is expected that in 2035 around 600 million people will suffer from the disease. A recent systematic review...
Detailed Description
This Prospective case-control study will be carried out with patients that will be admitted in the hospitalization areas of the Vall d'Hebron Hospital. All research data will be collected by the hospi...
Eligibility Criteria
Inclusion
- Peripheral venous access requirement \>7 days
- Administration of intravenous treatment
Exclusion
- Peripheral venous access for urgent or life-threatening pathology
- Acute psychiatric pathology
- Impossibility of peripheral venous access through the upper limb (amputations, extensive burns, etc.)
- History of venous thrombosis due to catheter less than 1 year
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2021
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04499638
Start Date
January 1 2020
End Date
May 15 2021
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall d'Hebron Research Institute-VHIR
Barcelona, Spain, 08035